Live from the NIH registry
Studies recruiting near Bakersfield right now
Top 25 of 66 recruiting studies, sorted by proximity — each links to its official registry page
Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease
Stargardt Disease
Phase 1, Phase 2
Interventional 18 participants sought
RayTx Clinical Site — Bakersfield, California (1.7 mi)
· Sponsor: Ray Therapeutics, Inc.
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
California Retina Consultants (CRC) - Bakersfield Office — Bakersfield, California (1.7 mi)
· Sponsor: Apellis Pharmaceuticals, Inc.
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Kern Research, Inc.- Site Number : 8400047 — Bakersfield, California (1.7 mi)
· Sponsor: Sanofi
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
California Retina Consultants-Bakersfield-65523 — Bakersfield, California (1.7 mi)
· Sponsor: Boehringer Ingelheim
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
National Institute of Clinical Research — Bakersfield, California (1.7 mi)
· Sponsor: CSL Behring
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Phase 3
Interventional 284 participants sought
Adverum Clinical Site 109 — Bakersfield, California (1.7 mi)
· Sponsor: Adverum Biotechnologies, Inc.
Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Phase 2
Interventional 15 participants sought
Adverum site 109 — Bakersfield, California (1.7 mi)
· Sponsor: Adverum Biotechnologies, Inc.
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Phase 3
Interventional 4,220 participants sought
Comprehensive Blood & Cancer Center — Bakersfield, California (1.7 mi)
· Sponsor: Stemline Therapeutics, Inc.
Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Retinitis Pigmentosa
Phase 2
Interventional 60 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi)
· Sponsor: jCyte, Inc
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Adventist Health - Bakersfield — Bakersfield, California (1.7 mi)
· Sponsor: Agendia
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Diabetic Macular Edema, DME
Phase 3
Interventional 240 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi)
· Sponsor: EyePoint Pharmaceuticals, Inc.
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
Severe Asthma
Phase 3
Interventional 786 participants sought
Research Site 13 — Bakersfield, California (1.7 mi)
· Sponsor: Generate Biomedicines
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi)
· Sponsor: NRG Oncology
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
Kern Research Inc. — Bakersfield, California (1.7 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
Eosinophilic Asthma
Phase 3
Interventional 400 participants sought
Research Site — Bakersfield, California (1.7 mi)
· Sponsor: AstraZeneca
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 2
Interventional 300 participants sought
Trovare Clinical Research - Bakersfield CA — Bakersfield, California (1.7 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi)
· Sponsor: NRG Oncology
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,000 participants sought
AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California (1.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
Multiple Myeloma
Phase 1
Interventional 134 participants sought
Comprehensive Blood and Cancer Center — Bakersfield, California (1.7 mi)
· Sponsor: Oncotherapeutics
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
AMD, nAMD
Phase 3
Interventional 714 participants sought
California Retina Consultants - Bakersfield /ID# 256240 — Bakersfield, California (1.7 mi)
· Sponsor: AbbVie
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
Macular Edema Secondary to Inflammation
Phase 3
Interventional 300 participants sought
California Retina Consultants (Bakersfield) — Bakersfield, California (1.7 mi)
· Sponsor: Kodiak Sciences Inc
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Asthma
Phase 2
Interventional 540 participants sought
Research Site — Bakersfield, California (1.7 mi)
· Sponsor: AstraZeneca
Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout
Burnout, Burnout Syndrome
N/A
Interventional 203 participants sought
Bakersfield VA Clinic, VA Greater Los Angeles Healthcare System — Bakersfield, California (1.7 mi)
· Sponsor: VA Greater Los Angeles Healthcare System
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD)
Phase 2
Interventional 324 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi)
· Sponsor: ONL Therapeutics
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
California Retina Consultants — Bakersfield, California (1.7 mi)
· Sponsor: Genentech, Inc.